HGG-21. GERMLINE MUTATIONS IN MSH2 GENE IN PEDIATRIC PATIENTS WITH CONGENITAL AND SPORADIC GLIOBLASTOMA

INTRODUCTION: Glioblastoma (GBM) remains one of the biggest therapeutic challenges in neuro-oncology. In spite of multimodal treatment approaches the prognosis of GBM is extremely poor, median survival is estimated about 12–16 months. Although GBM is one of the most common and malignant primary brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejmont, Maria, Rydzanicz, Małgorzata, Grajkowska, Wiesława, Perek-Polnik, Marta, Sowińska, Agnieszka, Kozłowska, Magdalena, Łastowska, Maria, Pronicki, Maciej, Płoski, Rafał, Dembowska-Bagińska, Bożenna, Trubicka, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
High Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715741/
http://dx.doi.org/10.1093/neuonc/noaa222.308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715741/
http://dx.doi.org/10.1093/neuonc/noaa222.308

Ejemplares similares